EDITORIAL
Published on 11 Sep 2025
Editorial: The role of adjuvant and neoadjuvant therapy in resectable esophageal cancer
doi 10.3389/fonc.2025.1688480
- 795 views
- Frontiers in Oncology
- Gastrointestinal Cancers: Gastric and Esophageal Cancers
- Research Topics
- The Role of Adjuvant and Neoadjuvant Therapy in Resectable Esophageal Cancer
The Role of Adjuvant and Neoadjuvant Therapy in Resectable Esophageal Cancer
1,459
Total downloads
7,586
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 21 May 2025
Impact of neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy on postoperative safety in locally advanced esophageal squamous cell carcinoma: a propensity score-matched retrospective cohort study
doi 10.3389/fonc.2025.1573597
- 1,272 views
ORIGINAL RESEARCH
Published on 13 May 2025
Safety and efficacy analysis of neoadjuvant radiotherapy combined with concurrent paclitaxel plus nedaplatin versus other platinum-based chemotherapy for thoracic segmental esophageal squamous cell carcinoma
doi 10.3389/fonc.2025.1582481
- 1,226 views
ORIGINAL RESEARCH
Published on 17 Jan 2025
Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy
doi 10.3389/fonc.2024.1426592
- 1,158 views
- 2 citations
ORIGINAL RESEARCH
Published on 14 Jan 2025
Higher 3-year recurrence-free survival rate in patients with complete pathological remission following neoadjuvant chemotherapy plus immunotherapy for esophageal cancer: a two-center, propensity score matching study
doi 10.3389/fonc.2024.1463936
- 1,212 views
